D

Dr Corp Ltd
SZSE:301177

Watchlist Manager
Dr Corp Ltd
SZSE:301177
Watchlist
Price: 28.65 CNY -1.04% Market Closed
Market Cap: ¥11.5B

EV/EBIT

279.3
Current
1 170%
Cheaper
vs 3-y average of -26.1

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
279.3
=
Enterprise Value
¥7.5B
/
EBIT
¥26.4m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
279.3
=
Enterprise Value
¥7.5B
/
EBIT
¥26.4m

Valuation Scenarios

Dr Corp Ltd is trading above its 5-year average

If EV/EBIT returns to its 5-Year Average (10.5), the stock would be worth ¥1.07 (96% downside from current price).

Statistics
Positive Scenarios
0/3
Maximum Downside
-96%
Maximum Upside
No Upside Scenarios
Average Downside
94%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 279.3 ¥28.65
0%
5-Year Average 10.5 ¥1.07
-96%
Industry Average 11.6 ¥1.19
-96%
Country Average 28.9 ¥2.96
-90%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
¥7.5B
/
Oct 2025
¥26.4m
=
279.3
Current
¥7.5B
/
Dec 2025
¥396.9m
=
18.9
Forward
¥7.5B
/
Dec 2026
¥760.8m
=
9.9
Forward
¥7.5B
/
Dec 2027
¥229.8m
=
32.7
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
CN
Dr Corp Ltd
SZSE:301177
11.5B CNY 279.3 84.7
FR
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
234.1B EUR 14.2 21.4
FR
Hermes International SCA
PAR:RMS
172.8B EUR 24.3 38.2
KR
SBW
KRX:102280
235.5T KRW -58 109.2 -117 637.1
CH
Compagnie Financiere Richemont SA
SIX:CFR
88.4B CHF 20.2 23.9
FR
EssilorLuxottica SA
PAR:EL
86B EUR 28.2 37.2
FR
Christian Dior SE
PAR:CDI
80.1B EUR 5.9 17.6
IN
Titan Company Ltd
NSE:TITAN
3.9T INR 57 82.7
FR
Kering SA
PAR:KER
29.4B EUR 24.9 416.7
CN
ANTA Sports Products Ltd
HKEX:2020
233.4B HKD 10.1 14.9
US
Tapestry Inc
NYSE:TPR
29.6B USD 19.2 56.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
D
Dr Corp Ltd
SZSE:301177
Average EV/EBIT: 48.3
279.3
N/A N/A
FR
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
14.2
8%
1.8
FR
Hermes International SCA
PAR:RMS
24.3
9%
2.7
KR
SBW
KRX:102280
Negative Multiple: -58 109.2 N/A N/A
CH
Compagnie Financiere Richemont SA
SIX:CFR
20.2
10%
2
FR
EssilorLuxottica SA
PAR:EL
28.2
23%
1.2
FR
Christian Dior SE
PAR:CDI
5.9
N/A N/A
IN
Titan Company Ltd
NSE:TITAN
57
29%
2
FR
Kering SA
PAR:KER
24.9
23%
1.1
CN
ANTA Sports Products Ltd
HKEX:2020
10.1
7%
1.4
US
Tapestry Inc
NYSE:TPR
19.2
13%
1.5
P/E Multiple
Earnings Growth PEG
CN
D
Dr Corp Ltd
SZSE:301177
Average P/E: 79.4
84.7
69%
1.2
FR
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
21.4
11%
1.9
FR
Hermes International SCA
PAR:RMS
38.2
12%
3.2
KR
SBW
KRX:102280
Negative Multiple: -117 637.1 N/A N/A
CH
Compagnie Financiere Richemont SA
SIX:CFR
23.9
16%
1.5
FR
EssilorLuxottica SA
PAR:EL
37.2
26%
1.4
FR
Christian Dior SE
PAR:CDI
17.6
N/A N/A
IN
Titan Company Ltd
NSE:TITAN
82.7
32%
2.6
FR
Kering SA
PAR:KER
416.7
186%
2.2
CN
ANTA Sports Products Ltd
HKEX:2020
14.9
10%
1.5
US
Tapestry Inc
NYSE:TPR
56.6
107%
0.5

Market Distribution

Higher than 94% of companies in China
Percentile
94rd
Based on 5 337 companies
94rd percentile
279.3
Low
0 — 16.6
Typical Range
16.6 — 52.9
High
52.9 —
Distribution Statistics
China
Min 0
30th Percentile 16.6
Median 28.9
70th Percentile 52.9
Max 49 021

Dr Corp Ltd
Glance View

In the bustling world of digital transformation, Dr Corp Ltd. has carved out its niche as an innovative leader that specializes in providing advanced software solutions tailored for the healthcare industry. Born out of a vision to streamline medical processes, the company has grown to become a pivotal player in the intersection of technology and medicine. At its core, Dr Corp Ltd. focuses on developing cutting-edge electronic health record systems, telemedicine platforms, and data analytics tools that aim to enhance patient care, streamline operations, and reduce costs for healthcare providers. Their suite of solutions is designed to integrate seamlessly into existing hospital infrastructure, offering medical practitioners intuitive tools for better data management and patient interaction. The revenue model of Dr Corp Ltd. is as sophisticated as its technology, embracing both subscription-based and licensing fees that provide a steady stream of income. Healthcare establishments often subscribe to Dr Corp's flagship software, drawn by its flexibility and ability to scale according to organizational needs. The company also capitalizes on its consulting services, offering bespoke solutions that include training and support to optimize the use of its products. This dual-pronged approach ensures a diversified income stream, allowing Dr Corp Ltd. to continually invest in research and development, staying ahead of technological curves and adapting to the ever-evolving demands of the healthcare industry. As a result, the firm maintains its reputation not only as a service provider but as a crucial partner in healthcare innovations.

Intrinsic Value
17.9 CNY
Overvaluation 38%
Intrinsic Value
Price ¥28.65
D
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett